Omnia Family Wealth’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AKTX
AC
CAM
WAM
PAI
SP
CAMG
XT
Omnia Family Wealth's AKTX Position: Q4 2025 in Review
Omnia Family Wealth sold out of Akari Therapeutics (AKTX) in Q4 2025, closing a stake of 711 shares — an estimated $28.7K sold.
Omnia Family Wealth first reported a position in AKTX in Q4 2019 and held it in 24 quarters. The position peaked at $1.1M in Q1 2021. 19 funds tracked by Wall St. Rank hold AKTX as of Q4 2025.
- Omnia Family Wealth reported no remaining Akari Therapeutics position as of Q4 2025 after selling out during the quarter.
- Omnia Family Wealth sold 711 Akari Therapeutics shares in Q4 2025, an estimated $28.7K.
- Omnia Family Wealth first reported a position in Akari Therapeutics in Q4 2019 and held it in 24 quarters.
- Omnia Family Wealth's Akari Therapeutics position peaked at $1.1M in Q1 2021.
- 19 funds tracked by Wall St. Rank held Akari Therapeutics as of Q4 2025.
Based on Omnia Family Wealth's 13F filing for Q4 2025, filed 16 Jan 2026.